Pharmacological inhibition of EZH2 disrupts the female germline epigenome.
Lexie ProkopukKirsten HoggPatrick S WesternPublished in: Clinical epigenetics (2018)
Together, these data demonstrate that drugs targeting EZH2 significantly affect the germline epigenome and, based on genetic models with oocyte-specific loss of EZH2 function, are likely to affect outcomes in offspring.